• 1. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 2. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 3. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 4. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 5. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Triazines 1,3,5-triazine-2,4-diamines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Triazines Aminotriazines 1,3,5-triazine-2,4-diamines

Introduction to 6-(Chloromethyl)-N-(2-phenylethyl)-1,3,5-triazine-2,4-diamine (CAS No. 104622-26-6)

The compound 6-(Chloromethyl)-N-(2-phenylethyl)-1,3,5-triazine-2,4-diamine, identified by its CAS number 104622-26-6, represents a significant molecule in the realm of pharmaceutical and biochemical research. This heterocyclic amine derivative features a triazine core substituted with functional groups that make it a versatile intermediate in the synthesis of various bioactive molecules. The presence of both a chloromethyl and two amino groups on the triazine ring endows the compound with unique reactivity, enabling its participation in nucleophilic substitution reactions that are pivotal for drug development.

Recent advancements in medicinal chemistry have highlighted the importance of triazine derivatives in the design of novel therapeutic agents. The structural motif of 1,3,5-triazine is well-documented for its ability to interact with biological targets such as enzymes and receptors, often serving as a scaffold for small-molecule drugs. In particular, the chloromethyl substituent on the triazine ring allows for facile introduction of other functional groups through nucleophilic addition reactions, making it an invaluable building block for constructing more complex pharmacophores.

The N-(2-phenylethyl) moiety in the compound's structure adds another layer of complexity and potential biological activity. The phenyl ring can engage in hydrophobic interactions with biological targets, while the ethyl group provides steric bulk that may influence binding affinity and selectivity. This combination of features has prompted researchers to explore its applications in developing treatments for various diseases, including inflammatory disorders and infectious diseases.

One of the most compelling areas of research involving 6-(Chloromethyl)-N-(2-phenylethyl)-1,3,5-triazine-2,4-diamine is its potential as a precursor for kinase inhibitors. Kinases are enzymes that play critical roles in cell signaling pathways and are frequently implicated in cancer and other chronic diseases. By modifying the structure of this triazine derivative, chemists have been able to generate analogs that exhibit inhibitory activity against specific kinases. For instance, studies have shown that derivatives of this compound can modulate the activity of tyrosine kinases, which are key targets in oncology research.

Another area where this compound has shown promise is in the development of antimicrobial agents. The chloromethyl group can be used to introduce sugar moieties or other antimicrobial scaffolds, leading to compounds with broad-spectrum activity against bacteria and fungi. Additionally, the N-(2-phenylethyl) group may contribute to enhanced membrane permeability or target-specific interactions, further improving efficacy.

The synthesis of 6-(Chloromethyl)-N-(2-phenylethyl)-1,3,5-triazine-2,4-diamine itself is an intricate process that requires careful control of reaction conditions to ensure high yield and purity. Typically, it involves multi-step reactions starting from readily available precursors such as cyanoguanidine and benzaldehyde derivatives. The introduction of the chloromethyl group is often achieved through chlorination reactions or by reacting a hydroxymethyl derivative with a chlorinating agent like thionyl chloride or phosphorus oxychloride.

In recent years, computational methods have been increasingly employed to optimize the synthesis and application of this compound. Molecular modeling techniques allow researchers to predict how different structural modifications will affect biological activity. By leveraging these tools alongside experimental data, scientists can rapidly screen potential derivatives and identify lead compounds for further development.

The pharmaceutical industry has also taken notice of the potential applications of 6-(Chloromethyl)-N-(2-phenylethyl)-1,3,5-triazine-2,4-diamine. Several companies have patented derivatives of this compound as part of their drug discovery programs. These patents often highlight specific modifications that enhance potency or reduce toxicity profiles while maintaining target specificity. Such efforts underscore the compound's significance as a pharmacological tool.

Looking ahead, future research on this molecule is likely to focus on expanding its therapeutic applications through structure-activity relationship (SAR) studies and exploring new synthetic pathways that improve efficiency and sustainability. Additionally, advances in biocatalysis may enable greener methods for producing this intermediate without compromising quality or yield.

In conclusion,6-(Chloromethyl)-N-(2-phenylethyl)-1,3,5-triazine-2,4-diamine (CAS No. 104622-26-6) is a multifaceted compound with substantial potential in pharmaceutical research. Its unique structural features make it an excellent candidate for designing novel drugs targeting various diseases. As our understanding of biological systems continues to grow,this molecule will undoubtedly play an important role in shaping future therapeutic strategies.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)